Compounding Pharmacy/Adulterated Drug Products
Similar Posts
Risk of False Positive Lead Test Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication
FDA is alerting health care providers and lab staff of reports of false positives when using certain Micro Capillary Blood Collection tubes with the LeadCare Testing Systems.Animal Model Qualification Program | AMQP
Information for requestors interested in submitting animal models for qualification to FDA’s Drug Development Tool (DDT) Programs.Continuous Ventilator Correction: Philips Respironics Updates Use Instructions for BiPAP A30, A40, and V30 Devices Due to Interruptions and/or Loss of Therapy
BiPAP A30, A40, and V30 devices may shut down due to a Ventilator Interruptions, leading to therapy loss. May cause serious injury or death.FDA Roundup: July 23, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.Primary Care Providers Can Prescribe with Confidence
Information and resources are available to help primary care providers manage OUD with the help of medications for opioid use disorder (MOUD).Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Applications and following the path to generic drug approval. Generic drug applications are termed “abbreviated” because they are generally not required to include preclinical (animal) and clinical (human) data to establish safety and effectiveness. Instead, generic applicants